investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Immune Evolution in Cancer

David L Woodland

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

No posts

Related projects

Conor C Lynch

Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Ann M Moormann

Impact of Malaria on Shaping Immunity to EBV in the Etiology of Burkitt lymphoma

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Riccardo Dalla-Favera

Role of Acetyltransferase Gene Inactivation in Follicular Lymphoma Pathogenesis

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Oliver W Press

Pretargeted Radioimmunotherapy of CD20+ Lymphomas

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Scott H Kaufmann

Regulation of Death Ligand-Induced Killing

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

William Figg

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Carl F Ware

HVEM-BTLA Pathway in Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Kelvin P Lee

CD28-Mediated Regulation of Multiple Myeloma Cell Proliferation and Survival

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies